Oncology News | pharmaphorum

Friday 28 August 2026

News

News

Pay offer rejected as ICR researchers continue strike action

Pay offer rejected as ICR researchers continue strike action

Researchers at the UK Institute of Cancer Research have held historic strikes over pay, claiming they are missing meals and struggling to cover bills.

News

Lumakras packaging

NICE aims to cut funding for Amgen lung cancer drug Lumykras

Amgen's Lumykras will no longer be funded by the Cancer Drugs Fund for KRAS-mutated lung cancer, says NHS reimbursement authority NICE.

News

Roche looks to Astex in $515m breast cancer deal

Roche looks to Astex in $515m breast cancer deal

Roche's Genentech unit has forged an alliance with Astex, worth up to $515m, to partner on a fragment-based drug discovery programme in breast cancer.

News

Novartis snaps up UK ADC developer Myricx Bio

Novartis snaps up UK ADC developer Myricx Bio

Novartis has reached a deal to buy Myricx Bio for up to $1.5bn, giving it control of the London, UK, start-up's ADC platform.

News

Dr Roger Cliffe

Olympic cyclist Chris Hoy praises cancer charity campaign

Sir Chris Hoy has said he is proud of participants in the Tour de 4 cycling event he set up last year to change perceptions of stage 4 cancer.

News

Levi Garraway

Roche's KRAS drug tops its rivals in lung cancer trial

Roche has thrown down the gauntlet to Amgen and Bristol Myers Squibb with new phase 3 data for its experimental KRAS G12C inhibitor, divarasib.